Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda Winters, Daniel A. Pollyea, Jeff Kaiser et al.|Blood Advances|2019Cited by 147
Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantationPrashant Sharma, Jonathan A. Gutman, Neel Gakhar et al.|Bone Marrow Transplantation|2019Cited by 39
Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy PopulationTaylor Morrisette, Jonathan A. Gutman, Amanda G. Van Matre et al.|Transplantation and Cellular Therapy|2019Cited by 38